Seahorse Bioscience

Tutorial: Measuring Bioenergetics in a Variety of Cell Types

David Ferrick
Guest Speaker:
David Ferrick
VP, Biology & Applications,
Seahorse Bioscience, Inc.

Webinar Abstract:

Recent discoveries have linked mitochondrial dysfunction and defects in cellular bioenergetics to the pathophysiology of many diseases including obesity, diabetes, cancer, cardiomyopathy and neurodegeneration. The introduction of Extracellular Flux (XF) technology has enabled non-invasive, real time profiling of cellular bioenergetics and mitochondrial function in living cells, opening a new window to study these diseases.

Also discussed:

  • How to prepare different cell types for XF analysis
  • How to assess bioenergetic profiles of various cell types
  • How to link bioenergetic profiles to cellular physiology

Assay:

Mitochondrial Function: BOFA (Glucose,) Glycolytic Compensation, FCCP
Substrate Utilization: Glucose, Palmitate, Etomoxin

 

Click here to registerLog In to View on-Demand

Originally presented July 17, 2008


References and Additional Links

 

Medical University of South Carolina

Beeson Research Group


Buck Institute for Age Research

The Nicholls Lab

Contact Information

David Ferrick, Ph.D
VP, Biology & Applications, Seahorse Bioscience, Inc.
Email: dferrick@seahorsebio.com

 


Selected Publications

1. Advances in Measuring Cellular Bioenergetics using Extracellular Flux. Ferrick DA, Neilson A, and Beeson C. (2008). Drug Discov Today, in press.

2. Multiparameter Metabolic Analysis Reveals a Close Link between Attenuated Mitochondrial Bioenergetics and Enhanced Glycolysis Dependency in Human Tumor Cells.". Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J, Chomicz S and Ferrick DA. (2007). Am J of Physiol Cell Physiol 292:C125-C136.